RUNX2 mutations in cleidocranial dysplasia

Genetics and Molecular Research

Volumn 12, Issue 4, 2013, Pages 4567-4574

  Lee, K E ^a   Seymen, F ^b   Ko, J ^a   Yildirim, M ^b   Tuna, E B ^a   Gencay, K ^b   Kim, J W ^a  

^a Seoul National University   (South Korea)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Cleidocranial dysplasia; Mutation; RUNX2; Supernumerary teeth

Indexed keywords

GENOMIC DNA; TRANSCRIPTION FACTOR RUNX2; RUNX2 PROTEIN, HUMAN; STOP CODON;

ADOLESCENT; ARTICLE; CASE REPORT; CHILD; CLEIDOCRANIAL DYSPLASIA; CLINICAL EXAMINATION; CLINICAL FEATURE; FAMILY STUDY; FEMALE; FRAMESHIFT MUTATION; GENE MUTATION; HUMAN; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NONSENSE MUTATION; PHENOTYPE; RUNX2 GENE; SCHOOL CHILD; THORAX RADIOGRAPHY; TOOTH MALFORMATION; GENETIC ASSOCIATION; GENETICS; JAW; NUCLEOTIDE SEQUENCE; RADIOGRAPHY; STOP CODON;

ADOLESCENT; BASE SEQUENCE; CHILD; CLEIDOCRANIAL DYSPLASIA; CODON, NONSENSE; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DNA MUTATIONAL ANALYSIS; FEMALE; FRAMESHIFT MUTATION; GENETIC ASSOCIATION STUDIES; HUMANS; JAW; MALE; MUTATION, MISSENSE; TOOTH ABNORMALITIES;

EID: 84885727714     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2013.October.15.5     Document Type: Article

References (35)

1. Afzal F, Pratap J, Ito K, Ito Y, et al. (2005). Smad function and intranuclear targeting share a Runx2 motif required for osteogenic lineage induction and BMP2 responsive transcription. J. Cell Physiol. 204: 63-72.
2. Ahn MY, Bae SC, Maruyama M and Ito Y (1996). Comparison of the human genomic structure of the Runt domain-encoding PEBP2/CBFalpha gene family. Gene 168: 279-280.
3. Aronson BD, Fisher AL, Blechman K, Caudy M, et al. (1997). Groucho-dependent and -independent repression activities of Runt domain proteins. Mol. Cell Biol. 17: 5581-5587.
4. Bae SC, Yamaguchi-Iwai Y, Ogawa E, Maruyama M, et al. (1993). Isolation of PEBP2 alpha B cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1. Oncogene 8: 809-814.
5. Bufalino A, Paranaiba LM, Gouvea AF, Gueiros LA, et al. (2012). Cleidocranial dysplasia: oral features and genetic analysis of 11 patients. Oral Dis. 18: 184-190.
6. Ducy P, Zhang R, Geoffroy V, Ridall AL, et al. (1997). Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89: 747-754.
7. Eggers JH, Stock M, Fliegauf M, Vonderstrass B, et al. (2002). Genomic characterization of the RUNX2 gene of Fugu rubripes. Gene 291: 159-167.
8. Geoffroy V, Corral DA, Zhou L, Lee B, et al. (1998). Genomic organization, expression of the human CBFA1 gene, and evidence for an alternative splicing event affecting protein function. Mamm. Genome 9: 54-57.
9. Hansen L, Riis AK, Silahtaroglu A, Hove H, et al. (2011). RUNX2 analysis of Danish cleidocranial dysplasia families. Clin. Genet. 79: 254-263.
10. Kanno T, Kanno Y, Chen LF, Ogawa E, et al. (1998). Intrinsic transcriptional activation-inhibition domains of the polyomavirus enhancer binding protein 2/core binding factor alpha subunit revealed in the presence of the beta subunit. Mol. Cell Biol. 18: 2444-2454.
11. Kim HJ, Nam SH, Kim HJ, Park HS, et al. (2006). Four novel RUNX2 mutations including a splice donor site result in the cleidocranial dysplasia phenotype. J. Cell Physiol. 207: 114-122.
12. Lee B, Thirunavukkarasu K, Zhou L, Pastore L, et al. (1997). Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nat. Genet. 16: 307-310.
13. Levanon D, Goldstein RE, Bernstein Y, Tang H, et al. (1998). Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors. Proc. Natl. Acad. Sci. U. S. A. 95: 11590-11595.
14. Li YL and Xiao ZS (2007). Advances in Runx2 regulation and its isoforms. Med. Hypotheses 68: 169-175.
15. Lin WD, Lin SP, Wang CH, Tsai Y, et al. (2011). RUNX2 mutations in Taiwanese patients with cleidocranial dysplasia. Genet. Mol. Biol. 34: 201-204.
16. Lo Muzio L, Tete S, Mastrangelo F, Cazzolla AP, et al. (2007). A novel mutation of gene CBFA1/RUNX2 in cleidocranial dysplasia. Ann. Clin. Lab. Sci. 37: 115-120.
17. Lu Y, Li Y, Cavender AC, Wang S, et al. (2012). Molecular studies on the roles of Runx2 and Twist1 in regulating FGF signaling. Dev. Dyn. 241: 1708-1715.
18. Maquat LE (2002). Molecular biology. Skiing toward nonstop mRNA decay. Science 295: 2221-2222.
19. Moore MJ (2002). RNA events. No end to nonsense. Science 298: 370-371
20. Mundlos S (1999). Cleidocranial dysplasia: clinical and molecular genetics. J. Med. Genet. 36: 177-182.
21. Mundlos S, Otto F, Mundlos C, Mulliken JB, et al. (1997). Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89: 773-779.
22. Ogawa T, Shimokawa H, Fukada K, Suzuki S, et al. (2003). Localization and inhibitory effect of basic fibroblast growth factor on chondrogenesis in cultured mouse mandibular condyle. J. Bone Miner. Metab. 21: 145-153.
23. Ott CE, Leschik G, Trotier F, Brueton L, et al. (2010). Deletions of the RUNX2 gene are present in about 10% of individuals with cleidocranial dysplasia. Hum. Mutat. 31: E1587-E1593.
24. Otto F, Kanegane H and Mundlos S (2002). Mutations in the RUNX2 gene in patients with cleidocranial dysplasia. Hum. Mutat. 19: 209-216.
25. Quack I, Vonderstrass B, Stock M, Aylsworth AS, et al. (1999). Mutation analysis of core binding factor A1 in patients with cleidocranial dysplasia. Am. J. Hum. Genet. 65: 1268-1278.
26. Ryoo HM, Kang HY, Lee SK, Lee KE, et al. (2010). RUNX2 mutations in cleidocranial dysplasia patients. Oral Dis. 16: 55-60.
27. Stewart M, Terry A, Hu M, O'Hara M, et al. (1997). Proviral insertions induce the expression of bone-specific isoforms of PEBP2alphaA (CBFA1): evidence for a new myc collaborating oncogene. Proc. Natl. Acad. Sci. U. S. A. 94: 8646-8651.
28. Suda N, Hamada T, Hattori M, Torii C, et al. (2007). Diversity of supernumerary tooth formation in siblings with cleidocranial dysplasia having identical mutation in RUNX2: possible involvement of non-genetic or epigenetic regulation. Orthod. Craniofac. Res. 10: 222-225.
29. Thirunavukkarasu K, Mahajan M, McLarren KW, Stifani S, et al. (1998). Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfbeta. Mol. Cell Biol. 18: 4197-4208.
30. Wagner E and Lykke-Andersen J (2002). mRNA surveillance: the perfect persist. J. Cell Sci. 115: 3033-3038.
31. Yoshida T, Kanegane H, Osato M, Yanagida M, et al. (2002). Functional analysis of RUNX2 mutations in Japanese patients with cleidocranial dysplasia demonstrates novel genotype-phenotype correlations. Am. J. Hum. Genet. 71: 724-738.
32. Zaidi SK, Javed A, Choi JY, van Wijnen AJ, et al. (2001). A specific targeting signal directs Runx2/Cbfa1 to subnuclear domains and contributes to transactivation of the osteocalcin gene. J. Cell Sci. 114: 3093-3102.
33. Zhang C, Zheng S, Wang Y, Zhao Y, et al. (2010). Mutational analysis of RUNX2 gene in Chinese patients with cleidocranial dysplasia. Mutagenesis 25: 589-594.
34. Zhang YW, Yasui N, Ito K, Huang G, et al. (2000a). A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc. Natl. Acad. Sci. U. S. A. 97: 10549-10554.
35. Zhang YW, Yasui N, Kakazu N, Abe T, et al. (2000b). PEBP2alphaA/CBFA1 mutations in Japanese cleidocranial dysplasia patients. Gene 244: 21-28.